Chronic pain education: past, present, and future of psychedelics for the management of chronic pain - Summary - MDSpire

Chronic pain education: past, present, and future of psychedelics for the management of chronic pain

  • By

  • Christopher L Robinson

  • Pawan K Solanki

  • Sean Snyder

  • Adam Amir

  • Antje Barreveld

  • Rory Vu Mather

  • Ivo H Cerda

  • Michael Motoc

  • Harman Chopra

  • Robert Jason Yong

  • Joel Castellanos

  • Timothy Furnish

  • Alan D Kaye

  • Vwaire Orhurhu

  • Trent Emerick

  • December 10, 2024

  • 0 min

Share

Objective:

To address the historical, pharmacological, and educational aspects of psychedelics in chronic pain management and propose a curriculum for future clinicians.

Key Findings:
  • Psychedelics act as 5HT2A receptor partial agonists, influencing mood and perception.
  • Research indicates potential therapeutic benefits of psychedelics for chronic pain and mental health conditions.
  • Current medical education lacks formal training on psychedelics despite increasing interest and usage.
Interpretation:

The evolving landscape of psychedelic research necessitates an integrated educational approach to prepare clinicians for future therapeutic applications.

Limitations:
  • Psychedelics are classified as Schedule I substances, complicating research and clinical use.
  • Stigmas associated with psychedelics from historical contexts may hinder acceptance in medical curricula.
Conclusion:

Incorporating psychedelics into medical education is essential for safe and effective patient care as research progresses.

Original Source(s)

Chronic pain education: past, present, and future of psychedelics for the management of chronic pain

  • by Christopher L Robinson, Pawan K Solanki, Sean Snyder, Adam Amir, Antje Barreveld, Rory Vu Mather, Ivo H Cerda, Michael Motoc, Harman Chopra, Robert Jason Yong, Joel Castellanos, Timothy Furnish, Alan D Kaye, Vwaire Orhurhu, Trent Emerick

  • December 10, 2024

Related Content

Urgent Care, Unchecked Power

An unsupervised clinic model and blurred boundaries expose how oversight can fail in outpatient care.

Wearables May Boost T2D Mobility

Outpatient intervention combined physiotherapist counseling with wrist-worn activity monitoring.

Decentralized Trials Expand Access—but Risk Inequity

Remote clinical research is proliferating fast. The field is still working out who gets left behind.